MRNA
Moderna, Inc. · Healthcare
Director Noubar Afeyan sold $1.9M of Moderna, Inc.
Sold$1,943,300
$194.33Price
10,000Shares
What MRNA did after the filing
- The stock from Mon, Jan 30 open, $187.23
- −19.2%
- S&P 500, same days
- −2.7%
Measured over 30 trading days, to the Mar 14 close.
Traded Wed, Jan 25. Filed Fri, Jan 27, 7:30 PM ET, after the close. Returns use the Jan 30 open and the Mar 14 close. Not investment advice.